Search
This year, the Robbins Family Awards for Nursing Excellence at Memorial Sloan Kettering held a deeper significance.
Learn more about from MSK experts about what the latest research on the connection between eating sugar and cancer risk.
A protein on certain immune cells is a promising target for making immunotherapy more effective against breast cancer.
Discover how Memorial Sloan Kettering’s Multidisciplinary Brain Metastasis Clinic is revolutionizing treatment for metastatic brain tumors.
Memorial Sloan Kettering experts are available to comment on new research presented at the American Association for Cancer Research 2016 Annual Meeting including immunotherapy and CAR T cells, exercise oncology, precision medicine and more. For more information and to set up interviews or access photos, email Nicole H. McNamara at [email protected].
New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments.
Experts from all specialties of breast cancer treatment will attend the 2018 San Antonio Breast Cancer Symposium from December 4 through 8. It is the largest annual meeting devoted solely to the latest in breast cancer advances. The meeting will highlight emerging research and also tackle some of the larger issues facing people with breast cancer and the doctors who treat them.
At Memorial Sloan Kettering Cancer Center’s 46th annual ceremony, graduating master's and PhD students were honored and award winners were recognized.
Learn how MSK is helping a young mother cope with rectal cancer through the Center for Young Onset Colorectal Cancer, the first program in the country devoted to younger adults with this disease.
The genome-editing technique uncovered several genes previously not known to influence embryonic development.